Search Results - "Thosani, Sonali"
-
1
Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress
Published in Current oncology reports (01-12-2017)“…Purpose of Review The purpose of this manuscript is to review the progress in the field of therapeutics for malignant pheochromocytomas and sympathetic…”
Get full text
Journal Article -
2
Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis
Published in Journal of clinical oncology (10-02-2013)“…The association between oral bisphosphonate (BP) intake and colorectal cancer (CRC) risk has been investigated in several recent studies with conflicting…”
Get full text
Journal Article -
3
Role of EUS-FNA-Based Cytology in the Diagnosis of Mucinous Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis
Published in Digestive diseases and sciences (01-10-2010)“…Background Preoperative diagnosis of malignancy in pancreatic cystic lesions (PCLs) remains challenging. Most non-mucinous cystic lesions (NMCLs) are benign,…”
Get full text
Journal Article -
4
The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2
Published in The journal of clinical endocrinology and metabolism (01-11-2013)“…Context: Pheochromocytoma (PHEO) occurs in 50% of patients with multiple endocrine neoplasia type 2 (MEN2). It is unknown if the presence of PHEO is associated…”
Get full text
Journal Article -
5
Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy
Published in Diabetes technology & therapeutics (01-12-2014)“…Hyperglycemia occurs in cancer patients receiving high-dose steroids with cyclophosphamide, doxorubicin, vincristine, and dexamethasone (hyper-CVAD) protocol…”
Get more information
Journal Article -
6
Reply to I.H. Sahin
Published in Journal of clinical oncology (10-07-2013)Get full text
Journal Article -
7
A CASE OF ACQUIRED GENERALIZED LIPODYSTROPHY ASSOCIATED WITH PEMBROLIZUMAB IN A PATIENT WITH METASTATIC MALIGNANT MELANOMA
Published in AACE clinical case reports (01-01-2020)“…To describe an unusual immune-related adverse event (irAE), acquired generalized lipodystrophy (AGL), from checkpoint inhibitor therapy in a patient treated…”
Get full text
Journal Article -
8
Lung cancer-induced paraneoplastic syndromes
Published in Current opinion in pulmonary medicine (01-07-2011)“…PURPOSE OF REVIEWParaneoplastic syndromes occur commonly in patients with lung cancer, especially cancers of neuroendocrine origin. The syndromes can be the…”
Get full text
Journal Article -
9
Identifying Trends in Glycemic Management in the Acute Cancer Care Center at MD Anderson Cancer Center
Published in The Journal of emergency medicine (01-01-2024)“…Hyperglycemia in the inpatient setting contributes to morbidity and mortality. Glycemic management in the emergency room setting is the initial gateway for…”
Get full text
Journal Article -
10
Characterizing hyperglycemia in cancer patients with diabetes in an Emergency Center
Published in The Journal of emergency medicine (01-11-2020)Get full text
Journal Article -
11
THU290 Identifying Trends In Glycemic Management In A Comprehensive Cancer Center
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: N. Kikani: None. S. Thosani: None. Hyperglycemia in the inpatient setting contributes to morbidity and mortality. Glycemic management in…”
Get full text
Journal Article -
12
Euglycemic DKA as an Initial Presentation of Immunotherapy-Induced Insulin-Dependent Diabetes
Published in Diabetes (New York, N.Y.) (01-07-2018)“…New onset insulin dependent diabetes (DM) has been reported in cancer patients (pts) receiving immunotherapy (IO). Typically, pts have Grade 3 hyperglycemia…”
Get full text
Journal Article -
13
THU325 Covid-19 Outcomes In Cancer Patients With Diabetes
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: E.T. Ngo: None. S. Thosani: None. Diabetes mellitus and cancer are risk factors for poor outcomes in patients with Covid-19 (Covid). In…”
Get full text
Journal Article -
14
Denosumab: a new agent in the management of hypercalcemia of malignancy
Published in Future oncology (London, England) (01-11-2015)“…Hypercalcemia of malignancy is an oncologic emergency due to tumoral factors that stimulate osteoclast-mediated bone resorption. It requires a combination of…”
Get full text
Journal Article -
15
Pancreatic volumes in immune checkpoint inhibitor-induced diabetes
Published in Journal of clinical oncology (20-05-2021)“…Abstract only 2644 Background: Immune checkpoint inhibitor-mediated insulin dependent diabetes (ICI-DM) is a rare and irreversible adverse event often…”
Get full text
Journal Article -
16
Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma
Published in European journal of endocrinology (01-09-2015)“…ObjectivePheochromocytomas (PHs) and sympathetic paragangliomas (PGs) are tumors that produce catecholamines, predisposing patients to cardiovascular disease…”
Get full text
Journal Article -
17
Diabetic Ketoacidosis With Alpelisib
Published in Journal of the Endocrine Society (03-05-2021)“…Abstract Background: Hyperglycemia is a frequently reported adverse effect of alpelisib, an isoform specific phosphoinositide 3 kinase inhibitor, which is…”
Get full text
Journal Article -
18
Surgical universal euglycemic attainment during recovery (SUGAR) initiative: Sweet results through quality improvement (286)
Published in Gynecologic oncology (01-08-2022)Get full text
Journal Article -
19
Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center
Published in Annals of surgical oncology (01-05-2024)“…Introduction To improve the detection and management of perioperative hyperglycemia at our tertiary cancer center, we implemented a glycemic control quality…”
Get full text
Journal Article -
20
FRI685 Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: M.D. Patil: None. S. Thosani: None. R.L. Bassett Jr: None. Z. Wang: None. T.A. Guise: None. Denosumab (dmab) is useful to treat conditions…”
Get full text
Journal Article